Compare stocks

Bonesupport Holding AB, founded in 1999 and headquartered in Lund, Sweden, specializes in developing and commercializing injectable bio-ceramic bone graft substitutes under the CERAMENT® brand. These products are designed to remodel into the patient's own bone and can elute drugs directly into bone voids. The company's portfolio includes CERAMENT® Bone Void Filler, CERAMENT® G, and CERAMENT® V, targeting conditions such as bone voids resulting from trauma, infection, or disease. In 2024, Bonesupport reported net sales of SEK 898.7 million, marking a 52% increase from the previous year. The company operates in Europe, North America, and other international markets, focusing on orthobiologics for bone injury management.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.